[1]
Kirac, D., Bayam, E., Dagdelen, M., Gezmis, H., Sarikaya, S., Pala, S., Altunok, E.C. and Genc, E. 2017. HMGCR and ApoE mutations may cause different responses to lipid lowering statin therapy. Cellular and Molecular Biology. 63, 10 (Oct. 2017), 43–48. DOI:https://doi.org/10.14715/cmb/2017.63.10.6.